Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianpi Yishen Huazhuo granules for vascular dementia
ChiCTR2400085454Phase 2Recruiting
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vascular dementia comparing Jianpi Yishen Huazhuo granules with Placebo (2 arms). Primary endpoints: VaDAS-Cog score and Chinese Medicine Symptom Score. Started Jun 2024; status: recruiting.
02
Drugs
jianpi yishen huazhuo granules
03
Conditions
vascular dementia
Beyond the preview
Go deeper on ChiCTR2400085454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085454.